Medicine & Life Sciences

1. Venous Thrombosis 100%
2. Bendamustine Hydrochloride 91%
3. Hemophilia A 84%
4. Rituximab 67%
5. Non-Hodgkin's Lymphoma 56%
6. Hemophilia B 40%
7. Hemorrhage 40%
8. Arthroplasty 31%
9. Multicenter Studies 27%
10. Factor VII Deficiency 26%
11. Half-Life 26%
12. Hospital Emergency Service 23%
13. Knee Replacement Arthroplasties 23%
14. Factor VIII 22%
15. Warfarin 22%
16. Mantle-Cell Lymphoma 22%
17. Idarubicin 21%
18. fibrin fragment D 21%
19. Patient Reported Outcome Measures 21%
20. Follicular Lymphoma 21%
21. von Willebrand Diseases 19%
22. Mitoxantrone 19%
23. Hip 19%
24. Ultrasonography 18%
25. Nomograms 18%
26. B-Cell Chronic Lymphocytic Leukemia 18%
27. Venous Thromboembolism 17%
28. Etoposide 17%
29. B-Cell Lymphoma 17%
30. Cytarabine 17%
31. von Willebrand Factor 16%
32. Hematuria 15%
33. Physicians 15%
34. Thrombosis 15%
35. Hodgkin Disease 15%
36. Leukemia 15%
37. Heparin 15%
38. Health 14%
39. Canada 14%
40. Acute Myeloid Leukemia 14%
41. Drug Therapy 13%
42. Safety 13%
43. Progression-Free Survival 13%
44. Cost-Benefit Analysis 12%
45. Acquired Factor 8 deficiency 12%
46. Pregnant Women 12%
47. Guidelines 11%
48. Quality of Life 11%
49. Phlebography 11%
50. Blood Platelets 11%